The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition
Dan Wang,
No information about this author
Yue Zhou,
No information about this author
Li Hua
No information about this author
et al.
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
131, P. 155786 - 155786
Published: May 28, 2024
Although
AMP-activated
protein
kinase
(AMPK)
has
been
extensively
studied
in
cellular
processes,
the
understanding
of
its
substrates,
downstream
functions,
contributions
to
cell
fate
and
colorectal
cancer
(CRC)
progression
remains
incomplete.
Language: Английский
Recent approaches in nanotoxicity assessment for drug delivery applications: Challenges and prospects
Medicine in Drug Discovery,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100204 - 100204
Published: Feb. 1, 2025
Language: Английский
Enterosoluble microcapsules embedded with tripeptide-modified zwitterionic nanosystems to overcome intestinal barriers for intact exocytosis and hepatic-targeted gradual insulin delivery
Yuhong Ma,
No information about this author
Bing Zhao,
No information about this author
Umm E. Hani
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 161732 - 161732
Published: March 1, 2025
Language: Английский
Nano-Phytoconstituents: Recent Advances, Regulatory Insights, Challenges, and Future Horizons
Journal of Drug Delivery Science and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106908 - 106908
Published: April 1, 2025
Language: Английский
Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery
Yuhong Ma,
No information about this author
Jingru Yang,
No information about this author
Yukun Ma
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 25, 2024
Abstract
Despite
the
potential
benefits
of
close‐looped
insulin
delivery
systems
in
regulating
glycemic
homeostasis
and
effectively
alleviating
diabetes,
they
still
encounter
challenges
such
as
limited
effectiveness
preventing
low
episodes
due
to
sluggish
glucose
response,
issues
with
instability
enzymes
carriers.
In
this
study,
dually‐crosslinked
oxidase
(GOx)‐immobilized
nanogels
(DC‐NGs@Ins)
are
developed
for
rapid‐responsive
sustained
hypoglycemic
therapy.
The
DC‐NGs@Ins
phenylborate
ester
linker
enabled
release
a
fashion,
moreover,
immobilized
GOx‐generated
hydrogen
peroxide
(H
2
O
)
by
consuming
glucose,
which
can
further
bind
enhancing
response
accelerating
release.
structure
(phenylboronic
UV‐crosslinking)
minimized
initial
burst
insulin,
thus
risk
hypoglycemia.
More
interestingly,
GOx
mitigated
leakage
enhanced
its
multiple
utilization
compared
free
GOx.
vivo
study
demonstrated
that
maintained
levels
(BGLs)
below
200
mg
dL
−1
at
least
8
h
singly‐crosslinked
(SC‐NGs@Ins).
Therefore,
intelligent
system
shows
applications
diabetes
treatment.
Language: Английский
Propionate-functionalized chitosan hydrogel nanoparticles for effective oral delivery of insulin
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
unknown, P. 139159 - 139159
Published: Dec. 1, 2024
Language: Английский
Effects of silica nanoparticle addition and PDMS coating on membrane performance and stability in the extraction of aromatic amines
Journal of Colloid and Interface Science,
Journal Year:
2024,
Volume and Issue:
683, P. 68 - 78
Published: Dec. 9, 2024
Language: Английский
The Application of Nanomaterials in the Treatment of Pancreatic-Related Diseases
Jing Ma,
No information about this author
Xue Li,
No information about this author
Chunru Wang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 13158 - 13158
Published: Dec. 7, 2024
Pancreatic
diseases,
typically
including
pancreatic
cancer,
pancreatitis,
and
diabetes,
pose
enormous
threats
to
people's
lives
health.
To
date,
therapeutics
with
high
therapeutic
efficacy
low
side
effects
are
still
challenging.
With
the
development
of
nanotechnology,
nanomaterials
have
successfully
been
applied
in
pancretic
disease
treatment.
Here,
we
first
introduce
diversity
their
different
physicochemical
properties
on
function.
Following
this,
analyze
potential
enhance
targeting
by
overcoming
challenges
traditional
delivery
methods
through
surface
modifications,
structural
adjustments,
optimized
drug
loading.
Then,
application
structurally
pancreatic-related
diseases.
For
instance,
cancer
(as
platforms,
for
promotion
radiation
therapy,
as
multifunctional
tools),
pancreatitis
systems,
anti-inflammatory
anti-fibrotic
agents),
diabetes
insulin
carriers,
protecting
β
cells,
improving
resistance).
Through
analysis
progress
current
research,
summarize
how
can
treatment
while
minimizing
effects.
Finally,
look
forward
prospects
Language: Английский